Nelson Vergel
Founder, ExcelMale.com
Curated By Nelson Vergel | ExcelMale.com | Updated May 2026
Most men know melatonin as the hormone that helps them fall asleep. But emerging research points to a far more compelling role for this molecule: the potential to slow, and perhaps partially reverse, one of the root causes of testosterone decline in aging men.
Late-onset hypogonadism (LOH) affects an estimated 7.8% of men aged 40 to 79, and its prevalence will continue to rise as the global population ages. The standard treatment -- testosterone supplementation therapy (TST) -- works by replacing what the body no longer makes. But TST is fundamentally a workaround. It does nothing to fix the aging Leydig cells that stopped producing testosterone in the first place.
A new wave of research, synthesized in a comprehensive 2024 to 2025 review, suggests that melatonin may be able to target the cellular machinery underlying testosterone decline. The science is still largely preclinical, but the mechanistic case is compelling enough to deserve serious attention from any man thinking about his long-term hormonal health.
Leydig cells reside in the interstitial compartment of the testes and serve as the primary manufacturing site for testosterone. As men age, these cells undergo what researchers now call functional senescence -- a state in which they stop dividing, lose metabolic efficiency, and progressively shut down hormone production.
This decline is not random. It is driven by two interconnected biological processes that reinforce each other in a damaging loop.
At the same time, mitochondrial dysfunction develops. Mitochondria supply both the energy and the physical platform for the early steps of testosterone synthesis. When they degrade, they generate even more ROS -- creating a self-amplifying spiral. Damaged mitochondria produce more cellular pollution, which further damages mitochondria, which then fail to power hormone production.
Eventually, this cycle triggers irreversible senescence through the p38 MAPK/p21 pathway, effectively locking the Leydig cell out of its own biosynthetic function.
TST vs. Melatonin: Two Different Approaches to Low Testosterone
A 2022 study on diabetic rats confirmed this pathway specifically in Leydig cells, showing that melatonin's activation of SIRT1 restored the steroidogenic enzyme expression that diabetes had suppressed -- including StAR and 3 beta-HSD, two proteins central to testosterone synthesis. Human studies have also linked melatonin supplementation to significantly reduced levels of 8-OHdG, a urinary biomarker of oxidative DNA damage.
• Biogenesis: Via the SIRT1/PGC-1 alpha pathway, melatonin promotes the growth of new mitochondria, reversing the age-related decline in mitochondrial density.
• Dynamics: It restores the balance between mitochondrial fusion and fission. Excessive fission -- fragmentation of mitochondria -- is a hallmark of Leydig cell aging and is directly countered by melatonin.
• MERCs reconstruction: Melatonin rebuilds Mitochondria-Endoplasmic Reticulum Contacts (MERCs), the structural bridges essential for lipid transport and the early steps of steroid synthesis. It does this through Nestin-dependent mechanisms, restoring the physical interface the cell needs to move cholesterol into the mitochondria.
Research published in Biology of Reproduction confirmed that endogenously elevated melatonin in transgenic mammals correlated with decreased Leydig cell apoptosis, increased testosterone output, and improved sperm quality -- with the Bax/Bcl2 mitochondrial pathway identified as the key mechanism.
Melatonin counters this through NF-kB pathway inhibition, which reduces the secretion of these inflammatory signals. It also disrupts the PARP-1-mediated epigenetic activation of SASP genes. In infertile men given 3 mg/day for three months, melatonin reduced testicular macrophage counts and local inflammatory markers including COX-2 and IL-1 beta -- a direct demonstration that these mechanisms operate in human testicular tissue.
As men age, the extracellular matrix surrounding Stem Leydig Cells (SLCs) becomes progressively stiffer. This stiffness activates mechanosensory channels called Piezo1, triggering a calcium influx that leads to the degradation of Gli1, a transcription factor essential for stem cell differentiation. Without Gli1, SLCs cannot mature into functional testosterone-producing cells -- and the Leydig cell population shrinks without replacement.
Melatonin intervenes by reconstructing the Nestin-mediated MERC architecture and modulating matrix metalloproteinases to remodel the extracellular matrix environment. This approach restores the differentiation potential of aged stem cells -- giving the body a new supply of functional Leydig cells rather than simply trying to keep the old ones alive longer.
Selected Evidence Summary: Melatonin and Testicular Function
It is important to note a critical caveat from this research: melatonin's effects are species-dependent. In photoperiod-sensitive breeding animals such as roosters, melatonin can actually inhibit testosterone synthesis -- which is why some studies in the literature show seemingly contradictory results. In mammals that are not photoperiod-dependent, including humans, the evidence consistently shows supportive or neutral effects on testosterone when melatonin is administered correctly.
TST remains the most clinically validated treatment for men with diagnosed LOH who have symptomatic, confirmed testosterone deficiency. If your free testosterone is below therapeutic thresholds and you have the associated symptoms, TST is the current standard of care.
However, TST is a one-way door that creates negative feedback on the HPG axis and often suppresses residual natural testosterone production. Melatonin operates differently. Rather than replacing the output, it works upstream -- attempting to restore the cellular machinery that generates the output. The therapeutic models are complementary rather than competitive.
Where melatonin appears most promising:
• Men in the 40s and 50s with borderline or early testosterone decline seeking preventive strategies before initiating TST
• Men on TST interested in preserving residual testicular function
• Men who cannot use TST due to fertility goals or medical contraindications
• Men looking to address the root-cause biology of hormonal aging rather than only managing symptoms
Researchers have also suggested combining melatonin with other targeted antioxidants -- including Vitamin C and lycopene -- to maximize suppression of the mitochondrial damage spiral. This is an emerging area that warrants clinical investigation.
As men age, these clock gene oscillations weaken. The daily testosterone pulse flattens. This is not a side effect of Leydig cell aging -- it is part of the pathology itself.
Melatonin serves as the primary endogenous circadian regulator. By upregulating Bmal1 and resynchronizing the internal clock of Leydig cells, melatonin helps restore the rhythmic transcription of steroidogenic genes. The goal is not just to produce testosterone, but to produce it on the schedule that the body's downstream systems are built to receive it.
There is an additional layer here that most people miss. Leydig cells themselves contain the enzymatic machinery to synthesize melatonin locally -- they express both the required enzymes and the MT1 and MT2 melatonin receptors. This suggests that declining testicular melatonin synthesis may be an independent contributor to LOH, separate from the pineal gland's output. Restoring local melatonin availability within the testicular compartment may matter as much as systemic levels.
1. Melatonin: Functional Significance for Optimal Cellular Physiology (Dr. Russell Reiter) -- Notes and discussion from a lecture by world-leading melatonin researcher Dr. Russell Reiter on melatonin's antioxidant mechanisms and circadian biology.
2. Does Melatonin Make Sex Feel Better? -- Community discussion on melatonin's reported effects on sexual function, libido, and orgasm quality.
3. Long-Term Melatonin Supplementation May Decrease Sperm Quality in Men -- Review of evidence and community debate on the potential sperm quality concerns with chronic melatonin use.
4. Protect Your Prostate with Good Sleep or Melatonin Supplements -- Discussion on melatonin's potential role in prostate health and its connection to sleep quality and hormonal regulation.
5. Melatonin as Potent as Letrozole in Inhibiting Aromatization of Testosterone to Estrogen -- Community analysis of a research claim about melatonin and aromatase inhibition, including important caveats from experienced members.
6. Melatonin Supplements Before Evening Meal -- Yes or No? -- Practical discussion on melatonin timing, meal interactions, and optimizing circadian alignment for supplementation.
7. Melatonin and Hemoglobin -- Community Data -- A thread reviewing a potential melatonin-hemoglobin interaction and community members sharing their blood work observations.
8. ExcelMale TRT and Hormonal Health Forum -- Full Thread Index -- Browse the full ExcelMale archive for 20+ years of community knowledge on testosterone, aging, and optimization strategies.
2. Yang M, Guan S, Tao J, et al. Melatonin promotes male reproductive performance and increases testosterone synthesis in mammalian Leydig cells. Biol Reprod. 2021;104(6):1322-1336. https://doi.org/10.1093/biolreprod/ioab046
3. Qi J, Yang M, Li X, et al. Melatonin alleviates oxidative stress damage in mouse testes induced by bisphenol A. Front Endocrinol. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC10910031/
4. Ma J, Han Y, Yang H, et al. Melatonin protects Leydig cells from HT-2 toxin-induced ferroptosis and apoptosis via glucose-6-phosphate dehydrogenase/glutathione-dependent pathway. Int J Biochem Cell Biol. 2023;159:106410. https://doi.org/10.1016/j.biocel.2023.106410
5. Heidarizadi S, Rashidi Z, Jalili C, Gholami M. Overview of biological effects of melatonin on testis: A review. Andrologia. 2022;54(11):e14597. https://doi.org/10.1111/and.14597
6. Protective effects of melatonin against physical injuries to testicular tissue: A systematic review and meta-analysis of animal models. Front Endocrinol. 2023;14:1123999. https://doi.org/10.3389/fendo.2023.1123999
7. Deng SL, Wang ZP, Jin C, et al. Melatonin promotes sheep Leydig cell testosterone secretion in a co-culture with Sertoli cells. Theriogenology. 2018;106:170-7. https://doi.org/10.1016/j.theriogenology.2017.10.021
8. Martin LJ, Touaibia M. Prevention of male late-onset hypogonadism by natural polyphenolic antioxidants. Nutrients. 2024;16(12):1815. https://doi.org/10.3390/nu16121815
9. Reiter RJ, Tan DX, Rosales-Corral S, Manchester LC. Mitochondria: Central organelles for melatonin's antioxidant and anti-aging actions. Molecules. 2018;23(2):509. https://doi.org/10.3390/molecules23020509
10. Frontiers. Rhythms of life: Melatonin, nutrition, sleep, and antioxidant strategies for healthy aging. Front Neurosci. 2026. https://doi.org/10.3389/fnins.2026.1736978
Melatonin is evolving from a sleep supplement into a candidate for something far more significant: a cellular repair agent that targets the root pathology of testosterone decline. By activating antioxidant defenses, restoring mitochondrial architecture, suppressing the inflammatory signals that spread cellular aging, and supporting the stem cell pool that replenishes Leydig cells, melatonin addresses multiple layers of the biology that TST simply bypasses.
The honest limitation is that the clinical evidence for melatonin as a testosterone-restoring therapy in humans is still in early stages. Animal models are impressive. Human data on oxidative and inflammatory endpoints is encouraging. But we do not yet have properly powered RCTs showing that melatonin meaningfully raises serum testosterone in men with LOH.
What we do have is a mechanistic case strong enough to justify taking it seriously -- and a safety profile favorable enough that it warrants discussion with your doctor, particularly if you are in the preventive window before testosterone decline becomes clinically significant.
For deeper context, see our related ExcelMale guides on free testosterone reference ranges, sex hormone-binding globulin, and the Bhasin dose-response study.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. The information presented is intended to summarize and synthesize published research and community discussion. Always consult a qualified healthcare provider before starting or modifying any hormone therapy, supplementation protocol, or medical treatment.
About ExcelMale.com
ExcelMale.com is the leading expert-moderated men's health forum, with 24,000+ members and more than 20 years of peer-reviewed discussion on testosterone replacement therapy, hormone optimization, sexual health, and longevity. The forum was founded by Nelson Vergel, a chemical engineer and patient advocate with 34+ years of personal experience on TRT.
Nelson is the author of Testosterone: A Man's Guide and Beyond Testosterone, and is the founder of DiscountedLabs.com, making affordable hormone blood panels accessible to men across the United States.
Most men know melatonin as the hormone that helps them fall asleep. But emerging research points to a far more compelling role for this molecule: the potential to slow, and perhaps partially reverse, one of the root causes of testosterone decline in aging men.
Late-onset hypogonadism (LOH) affects an estimated 7.8% of men aged 40 to 79, and its prevalence will continue to rise as the global population ages. The standard treatment -- testosterone supplementation therapy (TST) -- works by replacing what the body no longer makes. But TST is fundamentally a workaround. It does nothing to fix the aging Leydig cells that stopped producing testosterone in the first place.
A new wave of research, synthesized in a comprehensive 2024 to 2025 review, suggests that melatonin may be able to target the cellular machinery underlying testosterone decline. The science is still largely preclinical, but the mechanistic case is compelling enough to deserve serious attention from any man thinking about his long-term hormonal health.
What You Will Learn in This Article |
• Why Leydig cells age and how that drives testosterone decline • How melatonin acts on the root molecular causes of Leydig cell senescence • What animal and human evidence shows about melatonin and testosterone • How melatonin compares to TST as a therapeutic approach • What men considering melatonin supplementation should know right now |
Why Do Testosterone Levels Decline as Men Age?
The short answer: Leydig cells wear out. But the full story is more nuanced and more actionable.Leydig cells reside in the interstitial compartment of the testes and serve as the primary manufacturing site for testosterone. As men age, these cells undergo what researchers now call functional senescence -- a state in which they stop dividing, lose metabolic efficiency, and progressively shut down hormone production.
This decline is not random. It is driven by two interconnected biological processes that reinforce each other in a damaging loop.
What Is the ROS-Mitochondrial Damage Cycle, and Why Does It Matter?
Oxidative stress occurs when reactive oxygen species (ROS) accumulate faster than the cell's antioxidant defenses can neutralize them. In Leydig cells, this damages lipids, proteins, and DNA -- and critically, it disables the SIRT1/Nrf2 signaling axis that coordinates the cell's primary antioxidant response.At the same time, mitochondrial dysfunction develops. Mitochondria supply both the energy and the physical platform for the early steps of testosterone synthesis. When they degrade, they generate even more ROS -- creating a self-amplifying spiral. Damaged mitochondria produce more cellular pollution, which further damages mitochondria, which then fail to power hormone production.
Eventually, this cycle triggers irreversible senescence through the p38 MAPK/p21 pathway, effectively locking the Leydig cell out of its own biosynthetic function.
TST vs. Melatonin: Two Different Approaches to Low Testosterone
Feature | Testosterone Supplementation (TST) | Melatonin-Based Approach |
Primary goal | Symptom management / hormone replacement | Active cellular repair / functional restoration |
Mechanism | Exogenous androgen supply | Antioxidant, mitochondrial, stem cell, and circadian repair |
Impact on HPG axis | Negative feedback (suppressive) | Homeostatic modulation (restorative) |
Effect on endogenous synthesis | May accelerate Leydig cell decline | Supports endogenous synthesis and BTB integrity |
Fertility impact | Suppresses spermatogenesis | Supports spermatogenesis via microenvironment repair |
Evidence base | Extensive clinical trials | Primarily preclinical; early human studies promising |
Safety concerns | Cardiovascular, prostate, fertility risks | High safety profile; optimal dosing for LOH unknown |
How Does Melatonin Protect and Potentially Repair Aging Leydig Cells?
Melatonin is not a single-action molecule. It operates through at least four distinct pathways that target the core drivers of Leydig cell aging -- which is precisely why researchers find it so interesting for this application.Does Melatonin Activate the SIRT1-Nrf2 Antioxidant Pathway?
Yes. One of melatonin's primary actions is activating the SIRT1/Nrf2 signaling axis, which is the master regulatory network for cellular antioxidant defense. When SIRT1 is activated, it restores Nrf2 activity, which in turn switches on the expression of enzymes including SOD (superoxide dismutase) and GSH-Px (glutathione peroxidase) -- the primary tools cells use to neutralize ROS.A 2022 study on diabetic rats confirmed this pathway specifically in Leydig cells, showing that melatonin's activation of SIRT1 restored the steroidogenic enzyme expression that diabetes had suppressed -- including StAR and 3 beta-HSD, two proteins central to testosterone synthesis. Human studies have also linked melatonin supplementation to significantly reduced levels of 8-OHdG, a urinary biomarker of oxidative DNA damage.
Can Melatonin Restore Mitochondrial Function in Testosterone-Producing Cells?
The evidence here is particularly strong across multiple species. Melatonin restores mitochondrial function through three complementary mechanisms.• Biogenesis: Via the SIRT1/PGC-1 alpha pathway, melatonin promotes the growth of new mitochondria, reversing the age-related decline in mitochondrial density.
• Dynamics: It restores the balance between mitochondrial fusion and fission. Excessive fission -- fragmentation of mitochondria -- is a hallmark of Leydig cell aging and is directly countered by melatonin.
• MERCs reconstruction: Melatonin rebuilds Mitochondria-Endoplasmic Reticulum Contacts (MERCs), the structural bridges essential for lipid transport and the early steps of steroid synthesis. It does this through Nestin-dependent mechanisms, restoring the physical interface the cell needs to move cholesterol into the mitochondria.
Research published in Biology of Reproduction confirmed that endogenously elevated melatonin in transgenic mammals correlated with decreased Leydig cell apoptosis, increased testosterone output, and improved sperm quality -- with the Bax/Bcl2 mitochondrial pathway identified as the key mechanism.
Does Melatonin Suppress the Inflammatory Signals That Spread Leydig Cell Aging?
Senescent Leydig cells develop what researchers call a Senescence-Associated Secretory Phenotype (SASP). Rather than quietly fading, they become pro-inflammatory, releasing cytokines including IL-6, GDF15, and TNF-alpha that damage neighboring healthy cells and germ cells. Left unchecked, one aging cell can degrade the environment for many others.Melatonin counters this through NF-kB pathway inhibition, which reduces the secretion of these inflammatory signals. It also disrupts the PARP-1-mediated epigenetic activation of SASP genes. In infertile men given 3 mg/day for three months, melatonin reduced testicular macrophage counts and local inflammatory markers including COX-2 and IL-1 beta -- a direct demonstration that these mechanisms operate in human testicular tissue.
How Does Melatonin Support the Stem Cells That Replenish Leydig Cell Populations?
The long-term problem with Leydig cell aging is not just that existing cells deteriorate -- it is that the stem cell pool available to replace them also degrades.As men age, the extracellular matrix surrounding Stem Leydig Cells (SLCs) becomes progressively stiffer. This stiffness activates mechanosensory channels called Piezo1, triggering a calcium influx that leads to the degradation of Gli1, a transcription factor essential for stem cell differentiation. Without Gli1, SLCs cannot mature into functional testosterone-producing cells -- and the Leydig cell population shrinks without replacement.
Melatonin intervenes by reconstructing the Nestin-mediated MERC architecture and modulating matrix metalloproteinases to remodel the extracellular matrix environment. This approach restores the differentiation potential of aged stem cells -- giving the body a new supply of functional Leydig cells rather than simply trying to keep the old ones alive longer.
What Does the Research Evidence Say About Melatonin and Testosterone?
The evidence base is currently stronger in animals than in humans, but the human data that exists is encouraging, and the mechanistic logic is sound.Selected Evidence Summary: Melatonin and Testicular Function
Model | Intervention | Key Finding |
STZ-treated rats (diabetes model) | 10 mg/kg/day melatonin | Restored StAR and 3 beta-HSD expression; reversed testosterone suppression via SIRT1 pathway |
BPA-exposed mice | 10-20 mg/kg melatonin | Reversed oxidative Leydig cell damage; restored steroidogenic enzyme expression via MTNR1A receptors |
HT-2 toxin sheep Leydig cells | In vitro melatonin | Reversed ferroptosis and apoptosis via G6PD/glutathione pathway; restored testosterone secretion |
Transgenic melatonin-rich mammals | Endogenous elevation (AANAT overexpression) | Decreased Leydig cell apoptosis, increased testosterone production, improved sperm quality |
Infertile men (clinical) | 3 mg/day for 3+ months | Reduced testicular macrophage counts and inflammatory markers (COX-2, IL-1 beta) |
Varicocelectomy patients (clinical) | 400 mg/day for 3 months | Significantly improved sperm parameters, increased total antioxidant capacity and inhibin B |
Shift workers (clinical) | Melatonin supplementation | Reduced urinary 8-OHdG (oxidative DNA damage marker) |
It is important to note a critical caveat from this research: melatonin's effects are species-dependent. In photoperiod-sensitive breeding animals such as roosters, melatonin can actually inhibit testosterone synthesis -- which is why some studies in the literature show seemingly contradictory results. In mammals that are not photoperiod-dependent, including humans, the evidence consistently shows supportive or neutral effects on testosterone when melatonin is administered correctly.
Is Melatonin a Viable Alternative to Testosterone Therapy for Men with Low T?
Not as a direct substitute -- but potentially as a complementary strategy or a preventive approach for men whose testosterone decline is in early stages.TST remains the most clinically validated treatment for men with diagnosed LOH who have symptomatic, confirmed testosterone deficiency. If your free testosterone is below therapeutic thresholds and you have the associated symptoms, TST is the current standard of care.
However, TST is a one-way door that creates negative feedback on the HPG axis and often suppresses residual natural testosterone production. Melatonin operates differently. Rather than replacing the output, it works upstream -- attempting to restore the cellular machinery that generates the output. The therapeutic models are complementary rather than competitive.
Where melatonin appears most promising:
• Men in the 40s and 50s with borderline or early testosterone decline seeking preventive strategies before initiating TST
• Men on TST interested in preserving residual testicular function
• Men who cannot use TST due to fertility goals or medical contraindications
• Men looking to address the root-cause biology of hormonal aging rather than only managing symptoms
Researchers have also suggested combining melatonin with other targeted antioxidants -- including Vitamin C and lycopene -- to maximize suppression of the mitochondrial damage spiral. This is an emerging area that warrants clinical investigation.
What Does the Circadian Clock Have to Do with Testosterone Production?
More than most people realize. Testosterone secretion is not a constant process -- it is rhythmic, governed by core circadian clock genes including Bmal1, Per1, and Per2. These genes regulate the timing of steroidogenic enzyme transcription, essentially programming the Leydig cell to produce testosterone in synchronized daily pulses.As men age, these clock gene oscillations weaken. The daily testosterone pulse flattens. This is not a side effect of Leydig cell aging -- it is part of the pathology itself.
Melatonin serves as the primary endogenous circadian regulator. By upregulating Bmal1 and resynchronizing the internal clock of Leydig cells, melatonin helps restore the rhythmic transcription of steroidogenic genes. The goal is not just to produce testosterone, but to produce it on the schedule that the body's downstream systems are built to receive it.
There is an additional layer here that most people miss. Leydig cells themselves contain the enzymatic machinery to synthesize melatonin locally -- they express both the required enzymes and the MT1 and MT2 melatonin receptors. This suggests that declining testicular melatonin synthesis may be an independent contributor to LOH, separate from the pineal gland's output. Restoring local melatonin availability within the testicular compartment may matter as much as systemic levels.
Key Takeaways for Men on TRT and Those Considering It |
1. Testosterone decline is driven by a self-amplifying loop of oxidative stress and mitochondrial dysfunction in Leydig cells -- not simple "wear and tear." 2. Melatonin activates SIRT1/Nrf2 antioxidant defenses, restores mitochondrial architecture, suppresses inflammatory SASP signaling, and rebuilds the stem cell niche that replenishes Leydig cell populations. 3. Leydig cells contain melatonin receptors (MT1 and MT2) and may synthesize melatonin locally -- suggesting the testes have their own melatonin system that declines with age. 4. Human evidence for melatonin reducing testicular inflammation and oxidative damage exists, but large-scale RCTs for LOH have not yet been completed. 5. Melatonin is not a replacement for TST in diagnosed LOH, but may serve as a preventive or complementary tool for men seeking to preserve long-term endogenous testosterone capacity. 6. No standardized dosing protocol for LOH exists. Do not self-prescribe without consulting a qualified healthcare provider. |
Frequently Asked Questions
Does melatonin increase testosterone in humans?
There is no large-scale RCT confirming that melatonin raises serum testosterone in men with LOH. However, human studies confirm it reduces testicular oxidative stress and inflammation, and animal studies consistently show testosterone-supportive effects in mammals. The question of whether long-term melatonin supplementation translates to measurable testosterone increases in aging men awaits properly designed clinical trials.Can I take melatonin while on testosterone replacement therapy?
There is no known contraindication between melatonin and TRT. Some men report improved sleep quality on TRT when melatonin is added. Melatonin may also help preserve residual testicular function. That said, discuss any supplement additions with your prescribing physician, particularly given melatonin's potential effects on aromatase activity (some research suggests possible estradiol modulation at higher doses).What dose of melatonin should men use for hormonal health?
There is no established dosing protocol for LOH. Research in infertile men used 3 mg/day for three or more months. Doses up to 400 mg/day have been used in surgical recovery studies. For general antioxidant and sleep support, 0.5 to 5 mg at bedtime is the typical range. Higher doses (above 10 mg) should only be considered under medical supervision. Age-specific dosing guidelines for hormonal applications do not yet exist.Can melatonin lower estradiol or act like an aromatase inhibitor?
Some ExcelMale community discussions and older studies have raised the possibility that melatonin may inhibit aromatase activity at higher doses. The evidence is limited and does not meet the threshold for clinical application. If you are managing estradiol levels on TRT, do not use melatonin as an aromatase inhibitor substitute without monitoring your estradiol with blood work.Does long-term melatonin supplementation harm sperm quality?
An early study reported decreased sperm quality in a small number of men after long-term melatonin use -- possibly due to aromatase inhibition affecting testicular estradiol balance. However, other evidence shows melatonin improving sperm parameters. The literature is not conclusive. Men with active fertility goals should discuss this with a reproductive endocrinologist before using melatonin regularly.Related ExcelMale Forum Discussions
Explore what the ExcelMale community and our expert contributors have discussed on these related topics:1. Melatonin: Functional Significance for Optimal Cellular Physiology (Dr. Russell Reiter) -- Notes and discussion from a lecture by world-leading melatonin researcher Dr. Russell Reiter on melatonin's antioxidant mechanisms and circadian biology.
2. Does Melatonin Make Sex Feel Better? -- Community discussion on melatonin's reported effects on sexual function, libido, and orgasm quality.
3. Long-Term Melatonin Supplementation May Decrease Sperm Quality in Men -- Review of evidence and community debate on the potential sperm quality concerns with chronic melatonin use.
4. Protect Your Prostate with Good Sleep or Melatonin Supplements -- Discussion on melatonin's potential role in prostate health and its connection to sleep quality and hormonal regulation.
5. Melatonin as Potent as Letrozole in Inhibiting Aromatization of Testosterone to Estrogen -- Community analysis of a research claim about melatonin and aromatase inhibition, including important caveats from experienced members.
6. Melatonin Supplements Before Evening Meal -- Yes or No? -- Practical discussion on melatonin timing, meal interactions, and optimizing circadian alignment for supplementation.
7. Melatonin and Hemoglobin -- Community Data -- A thread reviewing a potential melatonin-hemoglobin interaction and community members sharing their blood work observations.
8. ExcelMale TRT and Hormonal Health Forum -- Full Thread Index -- Browse the full ExcelMale archive for 20+ years of community knowledge on testosterone, aging, and optimization strategies.
Key References
1. Wang P, Zhang S, Lin S, Lv Z. Melatonin ameliorates diabetic hyperglycaemia-induced impairment of Leydig cell steroidogenic function through activation of SIRT1 pathway. Reprod Biol Endocrinol. 2022;20(1):118. https://doi.org/10.1186/s12958-022-00991-62. Yang M, Guan S, Tao J, et al. Melatonin promotes male reproductive performance and increases testosterone synthesis in mammalian Leydig cells. Biol Reprod. 2021;104(6):1322-1336. https://doi.org/10.1093/biolreprod/ioab046
3. Qi J, Yang M, Li X, et al. Melatonin alleviates oxidative stress damage in mouse testes induced by bisphenol A. Front Endocrinol. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC10910031/
4. Ma J, Han Y, Yang H, et al. Melatonin protects Leydig cells from HT-2 toxin-induced ferroptosis and apoptosis via glucose-6-phosphate dehydrogenase/glutathione-dependent pathway. Int J Biochem Cell Biol. 2023;159:106410. https://doi.org/10.1016/j.biocel.2023.106410
5. Heidarizadi S, Rashidi Z, Jalili C, Gholami M. Overview of biological effects of melatonin on testis: A review. Andrologia. 2022;54(11):e14597. https://doi.org/10.1111/and.14597
6. Protective effects of melatonin against physical injuries to testicular tissue: A systematic review and meta-analysis of animal models. Front Endocrinol. 2023;14:1123999. https://doi.org/10.3389/fendo.2023.1123999
7. Deng SL, Wang ZP, Jin C, et al. Melatonin promotes sheep Leydig cell testosterone secretion in a co-culture with Sertoli cells. Theriogenology. 2018;106:170-7. https://doi.org/10.1016/j.theriogenology.2017.10.021
8. Martin LJ, Touaibia M. Prevention of male late-onset hypogonadism by natural polyphenolic antioxidants. Nutrients. 2024;16(12):1815. https://doi.org/10.3390/nu16121815
9. Reiter RJ, Tan DX, Rosales-Corral S, Manchester LC. Mitochondria: Central organelles for melatonin's antioxidant and anti-aging actions. Molecules. 2018;23(2):509. https://doi.org/10.3390/molecules23020509
10. Frontiers. Rhythms of life: Melatonin, nutrition, sleep, and antioxidant strategies for healthy aging. Front Neurosci. 2026. https://doi.org/10.3389/fnins.2026.1736978
Conclusion: Is It Time to Take Melatonin More Seriously for Testosterone Health?
The research suggests yes -- with important caveats.Melatonin is evolving from a sleep supplement into a candidate for something far more significant: a cellular repair agent that targets the root pathology of testosterone decline. By activating antioxidant defenses, restoring mitochondrial architecture, suppressing the inflammatory signals that spread cellular aging, and supporting the stem cell pool that replenishes Leydig cells, melatonin addresses multiple layers of the biology that TST simply bypasses.
The honest limitation is that the clinical evidence for melatonin as a testosterone-restoring therapy in humans is still in early stages. Animal models are impressive. Human data on oxidative and inflammatory endpoints is encouraging. But we do not yet have properly powered RCTs showing that melatonin meaningfully raises serum testosterone in men with LOH.
What we do have is a mechanistic case strong enough to justify taking it seriously -- and a safety profile favorable enough that it warrants discussion with your doctor, particularly if you are in the preventive window before testosterone decline becomes clinically significant.
For deeper context, see our related ExcelMale guides on free testosterone reference ranges, sex hormone-binding globulin, and the Bhasin dose-response study.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. The information presented is intended to summarize and synthesize published research and community discussion. Always consult a qualified healthcare provider before starting or modifying any hormone therapy, supplementation protocol, or medical treatment.
About ExcelMale.com
ExcelMale.com is the leading expert-moderated men's health forum, with 24,000+ members and more than 20 years of peer-reviewed discussion on testosterone replacement therapy, hormone optimization, sexual health, and longevity. The forum was founded by Nelson Vergel, a chemical engineer and patient advocate with 34+ years of personal experience on TRT.
Nelson is the author of Testosterone: A Man's Guide and Beyond Testosterone, and is the founder of DiscountedLabs.com, making affordable hormone blood panels accessible to men across the United States.
